INS and diabetes mellitus: Continuous Subcutaneous Insulin Infusion (CSII), also known as insulin pump therapy, has emerged as a key advancement in diabetes care, offering improved glycemic variability, lifestyle flexibility, and reduced hypoglycemic episodes.